BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 26063221)

  • 21. Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4.
    Yang Y; Meng H; Peng Q; Yang X; Gan R; Zhao L; Chen Z; Lu J; Meng QH
    Cancer Gene Ther; 2015 Jan; 22(1):23-9. PubMed ID: 25477028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Over-expression of microRNA-375 inhibits papillary thyroid carcinoma cell proliferation and induces cell apoptosis by targeting ERBB2.
    Wang XZ; Hang YK; Liu JB; Hou YQ; Wang N; Wang MJ
    J Pharmacol Sci; 2016 Feb; 130(2):78-84. PubMed ID: 26806295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Family of microRNA-146 Regulates RARβ in Papillary Thyroid Carcinoma.
    Czajka AA; Wójcicka A; Kubiak A; Kotlarek M; Bakuła-Zalewska E; Koperski Ł; Wiechno W; Jażdżewski K
    PLoS One; 2016; 11(3):e0151968. PubMed ID: 27011326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-31 Reduces Cell Growth of Papillary Thyroid Carcinoma by RNA-Binding Protein HuR.
    Wu D; Wang B; Shang J; Song J; Zhang H
    Clin Lab; 2015; 61(11):1625-34. PubMed ID: 26731986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-183 promotes proliferation and invasion in oesophageal squamous cell carcinoma by targeting programmed cell death 4.
    Ren LH; Chen WX; Li S; He XY; Zhang ZM; Li M; Cao RS; Hao B; Zhang HJ; Qiu HQ; Shi RH
    Br J Cancer; 2014 Nov; 111(10):2003-13. PubMed ID: 25211657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC).
    Jazdzewski K; Boguslawska J; Jendrzejewski J; Liyanarachchi S; Pachucki J; Wardyn KA; Nauman A; de la Chapelle A
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E546-53. PubMed ID: 21159845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma.
    Lv M; Zhang X; Li M; Chen Q; Ye M; Liang W; Ding L; Cai H; Fu D; Lv Z
    PLoS One; 2013; 8(7):e67591. PubMed ID: 23861775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of phosphatidylinositol 3-kinase regulatory subunit alpha, activator protein-1, and programmed cell death 4 in diagnosis of papillary thyroid carcinoma.
    Chen X; Wu W; Chen X; Gong X
    Tumour Biol; 2016 May; 37(5):6519-26. PubMed ID: 26637226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas.
    Wang YQ; Guo RD; Guo RM; Sheng W; Yin LR
    J Cell Biochem; 2013 Jul; 114(7):1464-73. PubMed ID: 23296900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer.
    Wei C; Luo Q; Sun X; Li D; Song H; Li X; Song J; Hua K; Fang L
    Int J Clin Exp Pathol; 2015; 8(7):7729-39. PubMed ID: 26339338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.
    Li R; Liu J; Li Q; Chen G; Yu X
    Tumour Biol; 2016 Mar; 37(3):3987-96. PubMed ID: 26482618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-182 targets CHL1 and controls tumor growth and invasion in papillary thyroid carcinoma.
    Zhu H; Fang J; Zhang J; Zhao Z; Liu L; Wang J; Xi Q; Gu M
    Biochem Biophys Res Commun; 2014 Jul; 450(1):857-62. PubMed ID: 24971532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-93 functions as an oncomiR for the downregulation of PDCD4 in gastric carcinoma.
    Liang H; Wang F; Chu D; Zhang W; Liao Z; Fu Z; Yan X; Zhu H; Guo W; Zhang Y; Guan W; Chen X
    Sci Rep; 2016 Mar; 6():23772. PubMed ID: 27021515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-3653-3p inhibited papillary thyroid carcinoma progression by regulating CRIPTO-1.
    Bai X; Xu Y; Liu Y
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):272-276. PubMed ID: 38279419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PDCD4 expression in thyroid neoplasia.
    Pennelli G; Fassan M; Mian C; Pizzi M; Balistreri M; Barollo S; Galuppini F; Guzzardo V; Pelizzo M; Rugge M
    Virchows Arch; 2013 Jan; 462(1):95-100. PubMed ID: 23212265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miRNA-183 suppresses apoptosis and promotes proliferation in esophageal cancer by targeting PDCD4.
    Yang M; Liu R; Li X; Liao J; Pu Y; Pan E; Yin L; Wang Y
    Mol Cells; 2014 Dec; 37(12):873-80. PubMed ID: 25518924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α.
    Huang C; Cai Z; Huang M; Mao C; Zhang Q; Lin Y; Zhang X; Tang B; Chen Y; Wang X; Qian Z; Ye L; Peng Y; Xu H
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E204-13. PubMed ID: 25423566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression.
    Sun Y; Shi T; Ma Y; Qin H; Li K
    Cell Cycle; 2020 Apr; 19(7):787-800. PubMed ID: 32075502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
    Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
    J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miRNA-106a directly targeting RARB associates with the expression of Na(+)/I(-) symporter in thyroid cancer by regulating MAPK signaling pathway.
    Shen CT; Qiu ZL; Song HJ; Wei WJ; Luo QY
    J Exp Clin Cancer Res; 2016 Jun; 35(1):101. PubMed ID: 27342319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.